Synthesis of Dihydrofuroaporphine Derivatives: Identification of a Potent and Selective Serotonin 5-HT1A Receptor Agonist

被引：36

作者：

Liu, Zhili ^{[2
]}

Zhang, Hai ^{[1
]}

Ye, Na ^{[2
]}

Zhang, Jing ^{[2
]}

Wu, QianQian ^{[1
]}

Sun, Peihua ^{[1
]}

Li, Linyong ^{[1
]}

Zhen, Xuechu ^{[1
]}

Zhang, Ao ^{[2
]}

机构：

[1] Chinese Acad Sci, Shanghai Inst Mat Med, Neuropharmacol Lab, Shanghai 201203, Peoples R China

[2] Chinese Acad Sci, SOMCL, Shanghai 201203, Peoples R China

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 53卷 / 03期

基金：

美国国家科学基金会;

关键词：

VENTRAL TEGMENTAL AREA; NIGRAL DOPAMINE NEURONS; ELEVATED PLUS-MAZE; (R)-APORPHINES SYNTHESIS; PARKINSONS-DISEASE; RAPHE NUCLEUS; RAT; PHARMACOLOGY; ANXIETY; COMPLICATIONS;

D O I：

10.1021/jm9015763

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of new aporphine analogues were synthesized and pharmacologically evaluated. 11-Allyloxy-(17), 11-propargyloxy-(20), and dihydrofuro-(19) aporphines displayed the highest affinity at the 5-HT1A receptor with K-i values of 12.0, 14.0, and 6.7 nM, respectively. The high binding potential of the diastereomeric mixture of aporphine 19 was found residing in the cis-diastereomer (cis-19). [S-35]GTP gamma S function assays on 5-HT1A receptor indicated that aporphines 17 and 20 were partial agonists, while trans-19 behaved as a high efficacy full antagonist and cis-19 was a full agonist. The agonistic property of cis-19 at the 5-HT1A receptor was further confirmed in vitro and in vivo. This compound may be useful as a potential treatment for anxiety.

引用

页码：1319 / 1328

页数：10

共 50 条

[21] Distinctive in vitro signal transduction profile of NLX-112, a potent and efficacious serotonin 5-HT1A receptor agonist
Newman-Tancredi, Adrian
Martel, Jean-Claude
Cosi, Cristina
Heusler, Peter
Lestienne, Fabrice
Varney, Mark A.
Cussac, Didier
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2017, 69 (09) : 1178 - 1190
[22] F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential
Koek, W
Patoiseau, JF
Assie, MB
Cosi, C
Kleven, MS
Dupont-Passelaigue, E
Carilla-Durand, E
Palmier, C
Valentin, JP
John, G
Pauwels, PJ
Tarayre, JP
Colpaert, FC
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 287 (01): : 266 - 283
[23] Identification of fluorinated (R)-(-)-aporphine derivatives as potent and selective ligands at serotonin 5-HT2C receptor
Xu, Yulong
Sromek, Anna W.
Neumeyer, John L.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (02) : 230 - 233
[24] Occupancy of Agonist Drugs at the 5-HT1A Receptor
R Alexander Bantick
Eugenii A Rabiner
Ella Hirani
Michiel H de Vries
Susan P Hume
Paul M Grasby
Neuropsychopharmacology, 2004, 29 : 847 - 859
[25] Occupancy of agonist drugs at the 5-HT1A receptor
Bantick, RA
Rabiner, EA
Hirani, E
de Vries, MH
Hume, SP
Grasby, PM
NEUROPSYCHOPHARMACOLOGY, 2004, 29 (05) : 847 - 859
[26] Regulation of agonist efficacy at the 5-HT1A receptor
McLoughlin, DJ
Evans, KJ
Clarke, WP
FASEB JOURNAL, 2001, 15 (04): : A219 - A219
[27] F15599, a highly selective serotonin 5-HT1A receptor agonist:: in vitro affinity and efficacy profile at native rat and recombinant human 5-HT1A receptors
Newman-Tancredi, A.
Assie, M. B.
Cosi, C.
Slot, L. Bruins
Cussac, D.
Martel, J. C.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S232 - S233
[28] An improved synthesis of the 5-HT1A receptor agonist Eptapirone free base
Peng, Wei
Chen, Jian
Liu, Hui
Li, Xiufang
Deng, Zhiwei
Yuan, Jing
Peng, Yizhou
Yang, Yanjing
Zhong, Shian
CHEMICAL PAPERS, 2019, 73 (06): : 1321 - 1331
[29] Neuronal Phenotype Dependency of Agonist-Induced Internalization of the 5-HT1A Serotonin Receptor
Bouaziz, Elodie
Emerit, Michel Boris
Vodjdani, Guilan
Gautheron, Vanessa
Hamon, Michel
Darmon, Michele
Masson, Justine
JOURNAL OF NEUROSCIENCE, 2014, 34 (01): : 282 - 294
[30] Vilazodone: A 5-HT1A Receptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders
Dawson, Lee A.
Watson, Jeannette M.
CNS NEUROSCIENCE & THERAPEUTICS, 2009, 15 (02) : 107 - 117

← 1 2 3 4 5 →